Clinical trials: All Solid Tumors

Neoplasms by Histologic Type

A Trial In Patients With Advanced Cancer And Leukemia

• Completed
• Age: 16 years and older
• Phase 1
• Results posted

This is a phase 1, dose escalating study to determine the safety of PF-03084014 in patients with advanced cancer and leukemia

Trial name

NCT00878189

Testing

PF-03084014

Where

10 sites in United States, Italy

Volunteers

72 people

Sponsor

Pfizer